耐药时代的脓毒症经验性抗菌治疗考量
综述讨论脓毒症与脓毒性休克患者经验性抗菌治疗的决策要点,强调应根据病情严重程度、感染部位与流行病学风险选择方案;血流动力学稳定的低危患者可先完善检查,而脓毒性休克患者需立即给予广谱抗菌药物。
要点
- 脓毒性休克患者应立即给予广谱抗菌药物
- 血流动力学稳定的低危脓毒症患者可先完善检查再治疗
- 经验性方案需结合患者与流行病学风险、可能感染源及病情严重程度确定
核心结论
- 脓毒症抗菌治疗需按病情严重程度分层决策,脓毒性休克应立即广谱用药,低危稳定患者可先进一步检查。
研究设计与样本
- 本文为综述,讨论脓毒症与脓毒性休克经验性抗菌治疗的决策考量。
主要发现
- 许多血流动力学稳定且病情低危的脓毒症患者可能受益于在开始治疗前进一步检查。
- 脓毒性休克患者需要紧急给予广谱抗菌药物。
- 精确的经验性方案由患者与流行病学风险因素、基于症状体征的可能感染源及病情严重程度共同决定。
临床怎么用
- 医院应实施质量改进措施,以帮助快速准确诊断脓毒症患者。
- 应确保抗菌药物在开具医嘱后以加快的方式给予患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients with sepsis present across a spectrum of infection sites and severity of illnesses requiring complex decision making at the bedside as to when prompt antibiotics are indicated and which regimen is warranted. Many hemodynamically stable patients with sepsis and low acuity of illness may benefit from further work up before initiating therapy, whereas patients with septic shock warrant emergent broad-spectrum antibiotics. The precise empiric regimen is determined by assessing patient and epidemiological risk factors, likely source of infection based on presenting signs and symptoms, and severity of illness. Hospitals should implement quality improvement measures to aid in the rapid and accurate diagnosis of septic patients and to ensure antibiotics are given to patients in an expedited fashion after antibiotic order.
引用
- Strich JR, Heil EL, Masur H, et al. Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance. J Infect Dis. 2020. PMID: 32691833. doi:10.1093/infdis/jiaa221
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。